D. Patel

No Difference Between Latiglutenase and Placebo in Reducing Villous Atrophy or Improving Symptoms in Patients With Symptomatic Celiac Disease

Joseph A. Murray, Ciarán P. Kelly, Peter H.R. Green et al. · Gastroenterology · 2016 · 131 citations · Full text

Difference Between Latiglutenase, Villous Atrophy, Clinical Presentation +3

Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype.

Xi‐Ming Sun, D. Patel, Joe Webb et al. · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · 1994 · 113 citations · Full text

Genetics, Genetic Epidemiology, Human Polymorphism +19

Identification of a point mutation in growth factor repeat C of the low density lipoprotein-receptor gene in a patient with homozygous familial hypercholesterolemia that affects ligand binding and intracellular movement of receptors.

Anne K. Soutar, Brian L. Knight, D. Patel · Proceedings of the National Academy of Sciences · 1989 · 84 citations · Full text

Genetics, Pathology, Molecular Biology +19

Purification of the<i>E.coli</i>ogt gene product to homogeneity and its rate of action on<i>O</i>⁶-methylguanine,<i>O</i>⁶-ethyiguanine and<i>O</i>⁴-methylthymine in dodecadeoxyribnucleotides

Mark C. Wilkinson, Philip M. Potter, Lynn Cawkwell et al. · Nucleic Acids Research · 1989 · 80 citations · Full text

Characterization of two new point mutations in the low density lipoprotein receptor genes of an English patient with homozygous familial hypercholesterolemia.

JC Webb, X-M. Sun, D. Patel et al. · Journal of Lipid Research · 1992 · 57 citations · Full text